Skip to search formSkip to main contentSkip to account menu

FG-4592

National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

GlycineIsoquinolines
analogs & derivatives

Narrower (1)

roxadustat

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Implementation of the HIF activator IOX-2 in routine doping controls - pilot study data.
Early 2020, racehorse doping cases revolved around the hypoxia-inducible factor (HIF) activator IOX-2. While the composition of… 
2018
2018
Compromised JMJD6 Histone Demethylase Activity Affects VHL Gene Repression in Preeclampsia
Context The von Hippel Lindau (VHL) protein is a key executor of the cellular hypoxic response that is compromised in… 
2018
2018
Detection of novel metabolite for Roxadustat doping by global metabolomics.
Roxadustat (FG-4592, Rox) is a stabilizer for hypoxia-inducible transcription factors (HIFs), which induce production of the… 
2016
2016
FG 4592 monocrystalline and preparation method thereof
The invention discloses a kind of FG 4592 monocrystalline, its monocrystalline X x ray diffration pattern x has the feature that… 
2016
2016
Prolyl Hydroxylase Inhibitor FG-4592 Radioprotects Against Lethal Fractionated Radiation in a Novel Preclinical Model
2013
2013
First-in-class anemia drug takes aim at Amgen's dominion
2013
2013
Newborns sequenced at NIH
volume 31 NumBeR 11 NovemBeR 2013 nature biotechnology subunits. Under hypoxic conditions, as HIF-PH requires oxygen as a… 
2012
2012
Texas legitimizes path around FDA oversight
2011
2011
253 Evaluation of FG-4592, a Novel Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, to Treat Anemia in Hemodialysis Patients
EVALUATION OF FG-4592, A NOVEL ORAL HYPOXIAINDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR, TO TREAT ANEMIA IN HEMODIALYSIS… 
2011
2011
254 Pharmacokinetics of Oral FG-4592 to Treat Anemia in Hemodialysis (HD) Patients (PTS)
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)